Get the Daily Brief
Latest Biotech News
AlphaFold expands into protein complexes: Massive database release
EMBL‑EBI, Google DeepMind, NVIDIA and Seoul National University released a large set of AI‑predicted structures for millions of protein complexes into the AlphaFold Database. The collaboration...
Researchers build neurobots with self‑organizing nervous systems
Teams led by the Wyss Institute and collaborators reported the first living cellular robots integrated with developing nervous systems—so‑called neurobots—that self‑organize neuronal networks and...
ARPA‑H backs AI platform to scale gene‑therapy manufacturing
ARPA‑H awarded BioCurie up to $9.3 million to develop an AI‑driven, data‑centric platform aimed at accelerating and de‑risking gene‑therapy manufacturing. BioCurie will partner with academic and...
Trenchant and Invetech target fully automated point‑of‑care CGT manufacturing
Trenchant BioSystems and Invetech confirmed a development partnership to commercialize the AutoCell platform, a fully automated cell‑and‑gene therapy (CGT) manufacturing system designed for...
CirCode cleared to start U.S. trial of circular RNA therapy
CirCode Biomed secured FDA clearance to begin a first‑in‑human clinical trial in the U.S. testing a circular RNA therapeutic, marking a significant milestone for an emergent modality. The company,...
Roche inks Nvidia deal to supercharge AI drug and diagnostic factory
Roche signed a partnership with Nvidia to bolster the pharma giant’s AI capabilities across drug discovery and diagnostic development, expanding compute infrastructure and software tools used to...
BioVie positions spinout for $19.7M IPO to fund liver‑disease program
BioVie announced plans for a roughly $19.7 million IPO for a spinout charged with developing a reformulated low‑blood‑pressure drug as a potential treatment for liver disease. The offering is...
Judge stays RFK Jr. vaccine overhaul – ACIP meetings and schedule frozen
A federal judge issued a stay on key elements of Health and Human Services Secretary Robert F. Kennedy Jr.’s effort to overhaul U.S. childhood vaccine policy, blocking the CDC’s revised...
AlphaFold database expands: Millions of protein complexes released
EMBL‑EBI, Google DeepMind, NVIDIA and Seoul National University released a vast set of AI‑predicted protein complex structures into the AlphaFold Database. The consortium published millions of...
Structure’s oral GLP‑1 shows injectable‑like efficacy – 44‑week Phase 2
Structure Therapeutics reported Phase 2 data showing its oral GLP‑1 agonist aleniglipron produced about 16% placebo‑adjusted weight loss at 44 weeks. The company plans to advance the candidate...
Masked ADC posts responses in CRC – partnership fallout follows
CytomX disclosed Phase 1 expansion data for its masked antibody‑drug conjugate Varseta‑M showing objective response rates of roughly 20–32% in late‑line metastatic colorectal cancer and...
BioMarin pauses Voxzogo dosing after hip safety signal
BioMarin halted dosing for certain patients in two mid‑stage Voxzogo (vosoritide) studies after independent trials flagged cases of slipped capital femoral epiphysis (SCFE). The company said the...
ARPA‑H awards $9.3M to BioCurie: building AI‑driven gene therapy manufacturing
ARPA‑H granted BioCurie up to $9.3 million to develop an AI‑powered digital platform for scalable gene therapy process development. BioCurie will integrate machine learning, modeling and...
Trenchant and Invetech to commercialize AutoCell: automated point‑of‑care CGT manufacturing
Trenchant BioSystems agreed with Invetech to develop and commercialize the AutoCell fully automated cell and gene therapy (CGT) manufacturing platform. Internal and independent data indicate...
Federal judge stays RFK Jr. vaccine actions: ACIP votes and schedule changes paused
A federal judge in Massachusetts stayed votes taken by Health and Human Services Secretary Robert F. Kennedy Jr.’s reconstituted Advisory Committee on Immunization Practices (ACIP), paused the...
Mayo Clinic engineers milk‑derived nanoparticles for targeted cholangiocarcinoma gene therapy
Mayo Clinic researchers reported a targeted gene‑delivery platform that uses milk‑derived nanoparticles to deliver precision therapeutics to cholangiocarcinoma tumors. The preclinical study showed...
Illumina and Veritas form preventive genomics consortium: whole‑genome sequencing for routine care
Illumina and Veritas Genetics launched a consortium to integrate whole‑genome sequencing into preventive healthcare pathways and create a consented clinical‑genomics dataset. Illumina will supply...
CirCode clears FDA IND for circular RNA therapy trial in the US
CirCode Biomed, a China‑based startup developing circular RNA therapeutics, received FDA clearance to begin a US clinical trial for its circular RNA candidate. The IND greenlight marks one of the...
Judge stays HHS vaccine overhaul — ACIP appointments and schedule frozen
A federal judge in Boston has issued a stay on major elements of Health Secretary Robert F. Kennedy Jr.’s overhaul of U.S. childhood vaccine policy, pausing 13 ACIP appointments and removing the...
Structure’s oral GLP‑1 posts 16% weight loss — company eyes Phase 3
Structure Therapeutics reported Phase 2 data showing its oral GLP‑1 candidate aleniglipron produced an average 16% body-weight reduction at 44 weeks, a result the company says approaches...